News
News Center
2022-06-28
The notice states: Leveraging the China (Zhejiang) Pilot Free Trade Zone (hereinafter referred to as Zhejiang FTZ), we will explore and advance clinical research in cutting-edge biomedical fields such as immune cells, stem cells, and gene therapy.
+
2022-06-09
The Action Plan emphasizes: Fully leveraging the legislative powers of the Special Economic Zones and their role as pilot areas for comprehensive authorization reforms, to drive the advancement of research and translation in cutting-edge technologies such as cell and gene therapies. It also calls for piloting policies that allow the conditional use of Hong Kong and Macao-registered and approved drugs, traditional Chinese medicines, and bio-based raw materials—currently not yet approved domestically—within licensed medical institutions, as well as facilitating cross-border circulation of these products.
+
2022-06-08
On June 6, at the "China in the Past Decade" press conference hosted by the Publicity Department of the CPC Central Committee, China's Minister of Science and Technology, Wang Zhigang, emphasized that in tackling the world's cutting-edge scientific and technological fields, we have consistently pursued both goal-oriented approaches and free explorations. As a result, we've achieved a series of original breakthroughs with global impact in areas such as quantum information, stem cells, and brain science.
+
2022-06-06
Stem cells—The new force restoring the gift of sight
Scientists and researchers around the world have never stopped pursuing the path to light, confident that in the near future, stem cells will pave the way for curing more eye diseases—and ultimately bring sight back to those who suffer from them.
+
2022-05-16
Downs, despite being injured, helped the Timberwolves clinch a playoff spot, and he’s hoping stem-cell therapy will allow him to avoid surgery—fully expected to recover in time before training camp begins.
+
2022-05-11
Encourage piloting reforms in areas such as cell therapy, traditional Chinese medicine, and the regulatory oversight of TCM medical devices, leveraging the advantages of free trade pilot zones and the Hainan Free Trade Port.
+
2022-05-09
Life and health are not just scientific issues—they are profound, universal questions that everyone must confront. Achieving a vibrant, healthy body is a simple yet deeply cherished aspiration for people everywhere, and it also remains the ultimate goal of stem-cell researchers. As a cutting-edge and rapidly evolving field within life sciences, stem cells still hold many unanswered mysteries that call for our relentless exploration. With each new breakthrough, stem-cell research continues to unlock innovative treatment strategies for complex and challenging diseases, paving the way for even greater contributions to human health in the years to come.
+
2022-05-05
Recently, the National Science and Technology Management Information System Public Service Platform released the "Notice from the Ministry of Science and Technology on Issuing the 2022 Project Application Guidelines for Key Special Projects such as 'Stem Cell Research and Organ Repair' under the National Key R&D Program," which outlines guidelines for nine key special projects.
+
2022-04-26
The strategic partnership between Jiuzhitang and Yifeng Pharmacy will further drive the sharing and deep integration of pharmaceutical industry and commercial resources in Hunan Province, setting a benchmark for the seamless integration of industry and commerce within Hunan's pharmaceutical sector—and ultimately fostering mutually beneficial collaboration to collectively contribute to the development of Traditional Chinese Medicine in both the nation and Hunan Province!
+
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy